Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1984-04-18
1986-01-28
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514317, 514326, 514336, 514389, 546193, 546194, 546210, 546278, 548309, 548311, 548312, 2602455, A61K 3155, C07D40112
Patent
active
045671761
ABSTRACT:
This invention relates to Mannich-furyl(thienyl, pyridyl or phenyl) alkylaminoimidazolinones which have histamine H.sub.2 -antagonist activity. A specific compound of this invention is 2-[2-(5-dimethylaminomethylfuran-2-ylmethylthio)-ethylamino]-1-methyl-imid azolin-4-one.
REFERENCES:
patent: 3932644 (1976-01-01), Durant et al.
patent: 3968216 (1976-07-01), Black et al.
patent: 4234588 (1980-11-01), Brown et al.
patent: 4385058 (1983-05-01), Cooper et al.
Derwent Abstract 72003C (EP 16,565).
Bond Robert T.
Foggio Richard D.
Keps Joan S.
Lourie Alan D.
Smith Kline & French Laboratories Limited
LandOfFree
4H-Imidazol-4-ones and their pharmaceutical use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4H-Imidazol-4-ones and their pharmaceutical use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4H-Imidazol-4-ones and their pharmaceutical use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1306423